Company Overview and News

362
Stock market investors could hardly ask for better conditions - MarketWatch

2018-06-14 marketwatch
About 80% of S&P 500 Index companies reported first-quarter earnings that exceeded analysts’ estimates. Yet the U.S. stock index dropped 1.2% in the year through March as investors grew worried that a recession was imminent.
HD XLNX LRCX C.WSA CAT GS.PRB GS.PRA TEL APH GOOG GS C.WS.B GLSSP SUOPY C.WS.A C.PRP C.PRU C.PRS NCLH JBK C.PRL CATR C GSC GS.PRICL C.PRJ TFG C.PRK PHM C.PRG MCHP GSJ C.PRC GS.PRJ GS.PRI BABA GOOGL C.PRPCL GS.PRD CGBBW GS.PRC 0700 MSFT SUMCF GS.PRN GJS GS.PRK

0
Nikkei rises to over 2-week high; non-ferrous metal stocks rally

2018-06-07 thehindubusinessline
Japan's Nikkei share average rose to more than two-week highs on Thursday morning to stay above a key technical level as it tracked Wall Street gains overnight, while non-ferrous metal stocks staged a rally after copper prices soared.
SUOPY TTDKF SUMCF

7
ON Semiconductor Performing Well As The Cycle Ages

2018-05-02 seekingalpha
ON Semiconductor did a little better than expected, with its key auto and industrial markets both still offering healthy demand.
SUOPY ON

2
Nikkei rises, supported by tech shares; Monex jumps

2018-04-26 reuters
TOKYO, April 26 (Reuters) - Japan’s Nikkei share average rose on Thursday, buoyed by tech shares, with index heavyweight Tokyo Electron jumping after it forecast strong profits for this fiscal year.
SUOPY ADTTF SUMCF 8035 TOELF ATEYY TOELY

2
Nikkei rises as chip-related stocks surge

2018-04-26 thehindubusinessline
The Nikkei was up 0.5 per cent at 22,332.32 points by midmorning. File Photo - Reuters
SUOPY ADTTF SUMCF 8035 TOELF ATEYY TOELY

2
Nikkei rises as chip-related stocks surge; Tokyo Electron jumps

2018-04-26 reuters
TOKYO, April 26 (Reuters) - Japan’s Nikkei share average rose on Thursday, buoyed by gains in U.S. shares overnight and a sharp jump in index heavyweight Tokyo Electron after it forecast strong profits for this fiscal year.
SUOPY ADTTF SUMCF 8035 TOELF ATEYY TOELY

0
Tokyo stocks edge down on rekindled trade concerns

2018-04-06 japantimes.co.jp
Stocks edged down on the Tokyo Stock Exchange Friday after concerns about trade tensions between Washington and Beijing were rekindled by plans announced by U.S. President Donald Trump to consider additional tariffs on China.
SUOPY ADTTF SUMCF ATEYY

88
Should Value Investors Care About Nvidia (NVDA)?

2018-03-26 zacks
Shares of Nvidia (NVDA - Free Report) moved higher in early morning trading Monday as tech investors look to rebound from the sector’s tough stretch of trading last week. Despite recent volatility, Nvidia is up about 21% over the past three months, underscoring the company’s position as a tech bellwether and proving that Wall Street is still infatuated with this red-hot growth stock.
SUOPY TXN STM ASYS NVDA INTC XCRA

2
CORRECTED-Japan machinery makers with China exposure take big hit amid trade war fears

2018-03-24 reuters
TOKYO (Reuters) - Shares of Japanese machinery makers with heavy exposure to China plummeted on Friday as China and the United States moved closer to a trade war that could damage global growth.
MRSKY SUOPY SUMCF 8035 TOELF TOELY

2
Japanese firms begin filing paperwork for U.S. tariff exemptions as trade, business chiefs play down impact

2018-03-24 japantimes.co.jp
Japanese companies have started the procedures for requesting exemptions from new U.S. tariffs on steel and aluminum imports that took effect Friday, informed sources said.
MRSKY SUOPY SUMCF 8035 TOELF TOELY

2
Japan machinery makers with China exposure take big hit amid trade war fears

2018-03-23 reuters
TOKYO, March 23 (Reuters) - Shares of Japanese machinery makers with heavy exposure to China plummeted on Friday as China and the United States moved closer to a trade war that could damage global growth.
MRSKY SUOPY SUMCF 8035 TOELF TOELY

17
Almost Everything Going Right For Shin-Etsu Chemical

2018-03-16 seekingalpha
Shin-Etsu is reaping the benefits of both market and margin leadership in PVC and silicon wafers, as these markets are seeing very healthy operating conditions.
OLN SUOPY WLK BAK INTC TSM

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

7h - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

8h - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

CUSIP: 86558P109